The Clinical Trials Conundrum With Allan Shaw
Source: Bioprocess Online
The clinical trials status quo is a roadblock. They're slow, they're inefficient, and they're expensive. On this episode of the Business of Biotech, friend and frequent guest Allan Shaw shares some strong opinions on what's wrong with clinical trials, and what the industry (read: you) and the FDA need to do to make them right.
This website uses cookies to ensure you get the best experience on our website. Learn more